S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
S&P 500   4,293.93 (+0.62%)
DOW   33,833.61 (+0.50%)
QQQ   353.15 (+1.24%)
AAPL   180.57 (+1.55%)
MSFT   325.26 (+0.58%)
META   264.58 (+0.37%)
GOOGL   122.14 (-0.29%)
AMZN   124.25 (+2.49%)
TSLA   234.86 (+4.58%)
NVDA   385.10 (+2.76%)
NIO   7.79 (+0.39%)
BABA   86.14 (+1.01%)
AMD   121.05 (+2.73%)
T   16.07 (-0.19%)
F   13.58 (-0.07%)
MU   65.32 (-2.59%)
CGC   0.69 (-3.97%)
GE   106.07 (+-0.01%)
DIS   92.53 (+0.01%)
AMC   4.68 (-1.06%)
PFE   39.09 (+0.51%)
PYPL   64.24 (+0.31%)
NFLX   409.37 (+2.40%)
NYSE:MYTE

MYT Netherlands Parent B.V. (MYTE) Stock Forecast, Price & News

$4.10
+0.13 (+3.27%)
(As of 04:33 PM ET)
Compare
Today's Range
$3.91
$4.18
50-Day Range
$3.80
$7.49
52-Week Range
$3.75
$15.90
Volume
188,662 shs
Average Volume
108,794 shs
Market Capitalization
$348.01 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$10.75

MYT Netherlands Parent B.V. MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.50 Rating Score
Upside/​Downside
160.9% Upside
$10.75 Price Target
Short Interest
Healthy
0.43% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.55mentions of MYT Netherlands Parent B.V. in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
47.83%
From $0.23 to $0.34 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.52 out of 5 stars

Retail/Wholesale Sector

48th out of 208 stocks

Catalog & Mail-Order Houses Industry

3rd out of 13 stocks


MYTE stock logo

About MYT Netherlands Parent B.V. (NYSE:MYTE) Stock

MYT Netherlands Parent B.V., through its subsidiary, Mytheresa Group GmbH, operates a luxury e-commerce platform for fashion consumers in Germany, the United States, rest of Europe, and internationally. It offers womenswear, menswear, kids wear, and lifestyle products. The company sells clothes, bags, shoes, accessories, and fine jewelry through online and retail stores. It serves high-income luxury consumers. The company was founded in 1987 and is based in Munich, Germany.

Receive MYTE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MYT Netherlands Parent B.V. and its competitors with MarketBeat's FREE daily newsletter.

MYTE Stock News Headlines

The single greatest medical breakthrough of all time?
We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.
MYT Netherlands Parent B.V. (NYSE:MYTE) PT Lowered to $6.00
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
MYT Netherlands Parent B.V. (NYSE:MYTE) Trading Down 3.3%
MYT Netherlands Parent B.V. (NYSE:MYTE) Trading Up 5.4%
See More Headlines

MYTE Price History

MYTE Company Calendar

Last Earnings
11/11/2021
Today
6/08/2023
Fiscal Year End
6/30/2023
Next Earnings (Estimated)
9/21/2023

Industry, Sector and Symbol

Industry
Catalog & mail-order houses
Sub-Industry
N/A
Fax
N/A
Employees
1,238
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$10.75
High Stock Price Forecast
$17.00
Low Stock Price Forecast
$6.00
Forecasted Upside/Downside
+170.8%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.50
Research Coverage
8 Analysts

Profitability

Net Income
$-8,900,000.00
Pretax Margin
-0.60%

Debt

Sales & Book Value

Annual Sales
$777.64 million
Cash Flow
$0.73 per share
Book Value
$5.76 per share

Miscellaneous

Free Float
83,268,000
Market Cap
$336.97 million
Optionable
Not Optionable
Beta
1.05

Key Executives

  • Mr. Michael Kliger (Age 56)
    CEO & Chairman of Management Board
  • Dr. Martin Beer (Age 54)
    CFO & Member of Management Board
  • Mr. Sebastian Dietzmann (Age 48)
    COO & Member of Management Board
  • Mr. Gareth Locke (Age 47)
    Chief Growth Officer & Member of Management Board
  • Ms. Isabel May (Age 49)
    Chief Customer Experience Officer & Member of Management Board
  • Mr. Richard Johnson
    Chief Commercial Officer
  • Ms. Heather Kaminetsky
    Pres of North America













MYTE Stock - Frequently Asked Questions

Should I buy or sell MYT Netherlands Parent B.V. stock right now?

8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for MYT Netherlands Parent B.V. in the last twelve months. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MYTE shares.
View MYTE analyst ratings
or view top-rated stocks.

What is MYT Netherlands Parent B.V.'s stock price forecast for 2023?

8 Wall Street research analysts have issued 12-month target prices for MYT Netherlands Parent B.V.'s stock. Their MYTE share price forecasts range from $6.00 to $17.00. On average, they expect the company's share price to reach $10.75 in the next year. This suggests a possible upside of 170.8% from the stock's current price.
View analysts price targets for MYTE
or view top-rated stocks among Wall Street analysts.

How have MYTE shares performed in 2023?

MYT Netherlands Parent B.V.'s stock was trading at $8.91 at the beginning of the year. Since then, MYTE shares have decreased by 55.4% and is now trading at $3.97.
View the best growth stocks for 2023 here
.

Are investors shorting MYT Netherlands Parent B.V.?

MYT Netherlands Parent B.V. saw a decline in short interest in April. As of April 30th, there was short interest totaling 363,000 shares, a decline of 20.0% from the April 15th total of 453,700 shares. Based on an average daily volume of 120,000 shares, the days-to-cover ratio is currently 3.0 days.
View MYT Netherlands Parent B.V.'s Short Interest
.

When is MYT Netherlands Parent B.V.'s next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, September 21st 2023.
View our MYTE earnings forecast
.

How were MYT Netherlands Parent B.V.'s earnings last quarter?

MYT Netherlands Parent B.V. (NYSE:MYTE) announced its quarterly earnings data on Thursday, November, 11th. The company reported $0.10 earnings per share for the quarter, missing analysts' consensus estimates of $0.11 by $0.01. The business earned $186.10 million during the quarter, compared to analyst estimates of $192.43 million. MYT Netherlands Parent B.V. had a negative net margin of 1.05% and a positive trailing twelve-month return on equity of 5.34%.

What guidance has MYT Netherlands Parent B.V. issued on next quarter's earnings?

MYT Netherlands Parent B.V. updated its FY 2023 earnings guidance on Thursday, June, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $804.93 million-$821.03 million, compared to the consensus revenue estimate of $835.85 million.

When did MYT Netherlands Parent B.V. IPO?

(MYTE) raised $267 million in an IPO on Thursday, January 21st 2021. The company issued 15,700,000 shares at a price of $16.00-$18.00 per share. Morgan Stanley​ and J.P. Morgan acted as the underwriters for the IPO and Credit Suisse, UBS Investment Bank, Jefferies and Cowen were co-managers.

What is MYT Netherlands Parent B.V.'s stock symbol?

MYT Netherlands Parent B.V. trades on the New York Stock Exchange (NYSE) under the ticker symbol "MYTE."

Who are MYT Netherlands Parent B.V.'s major shareholders?

MYT Netherlands Parent B.V.'s stock is owned by a variety of institutional and retail investors. Top institutional investors include Sylebra Capital Ltd (4.60%), TimesSquare Capital Management LLC (1.87%), Fred Alger Management LLC (1.53%), Allspring Global Investments Holdings LLC (0.87%), Franklin Resources Inc. (0.84%) and Envestnet Asset Management Inc. (0.19%).

How do I buy shares of MYT Netherlands Parent B.V.?

Shares of MYTE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is MYT Netherlands Parent B.V.'s stock price today?

One share of MYTE stock can currently be purchased for approximately $3.97.

How much money does MYT Netherlands Parent B.V. make?

MYT Netherlands Parent B.V. (NYSE:MYTE) has a market capitalization of $336.97 million and generates $777.64 million in revenue each year. The company earns $-8,900,000.00 in net income (profit) each year or ($0.09) on an earnings per share basis.

How many employees does MYT Netherlands Parent B.V. have?

The company employs 1,238 workers across the globe.

How can I contact MYT Netherlands Parent B.V.?

MYT Netherlands Parent B.V.'s mailing address is EINSTEINRING 9, ASCHHEIM/MUNICH 2M, 85609. The official website for the company is www.mytheresa.com. The company can be reached via phone at 49-8912-769-5148 or via email at investors@mytheresa.com.

This page (NYSE:MYTE) was last updated on 6/8/2023 by MarketBeat.com Staff

My Account -